US EditionPublished • loading... • Updated
IDEXX Laboratories, Inc. $IDXX Shares Sold by Barclays PLC
Barclays sold 68,510 shares, reducing its IDEXX Laboratories stake to 236,670 shares valued at $151.2 million, according to SEC filings for Q3.
Summary by defenseworld.net
1 Articles
1 Articles
IDEXX Laboratories, Inc. $IDXX Shares Sold by Barclays PLC
Barclays PLC reduced its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 22.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 236,670 shares of the company’s stock after selling 68,510 shares during the quarter. Barclays PLC owned 0.30% of IDEXX Laboratories worth $151,206,000 at the end of the most recent quarter. Several other la…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
